Eastman Chemical (EMN) Misses Q3 EPS by 4c; Guides Lower

Eastman Chemical (NYSE: EMN) reported Q3 EPS of $2.05, $0.04 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $2.71 billion versus the consensus estimate of $2.6 billion.

GUIDANCE:

Eastman Chemical sees Q4 2022 EPS of $1.10-$1.40, versus the consensus of $1.82.

Eastman Chemical sees FY2022 EPS of $8.05-$8.35, versus the consensus of $8.75.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Rothschild Redburn Upgrades Apple (AAPL) to Buy
• Morgan Stanley Starts Target Hospitality (TH) at Overweight